These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1269501)
1. Methods for detecting teratogenic agents in man. Shepard TH; Miller JR Environ Health Perspect; 1976 Feb; 13():141-6. PubMed ID: 1269501 [TBL] [Abstract][Full Text] [Related]
2. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Brent RL Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188 [TBL] [Abstract][Full Text] [Related]
3. The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology. Czeizel AE Expert Opin Drug Saf; 2009 May; 8(3):283-303. PubMed ID: 19505262 [TBL] [Abstract][Full Text] [Related]
4. [Environmental and occupational factors in the development of congenital malformations]. Marcickiewicz J; Chazan B; Troszyński M; Szmigielski S Probl Med Wieku Rozwoj; 1983; 12():190-202. PubMed ID: 6674973 [TBL] [Abstract][Full Text] [Related]
5. Human teratogens: update 2010. Holmes LB Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353 [TBL] [Abstract][Full Text] [Related]
6. Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks. van Gelder MM; de Jong-van den Berg LT; Roeleveld N Hum Reprod; 2014 Jan; 29(1):168-83. PubMed ID: 24108217 [TBL] [Abstract][Full Text] [Related]
7. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing. Webster WS; Brown-Woodman PD; Ritchie HE Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342 [TBL] [Abstract][Full Text] [Related]
8. Teratogenic interaction of hyperthermia and vitamin A. Ferm VH; Ferm RR Biol Neonate; 1979; 36(3-4):168-72. PubMed ID: 486606 [TBL] [Abstract][Full Text] [Related]
9. [Theoretical and applied aspects of experimental teratology]. Dyban AP Ontogenez; 1977; 8(6):582-98. PubMed ID: 414184 [TBL] [Abstract][Full Text] [Related]
10. Counselling pregnant women at the crossroads of Europe and Asia: effect of Teratology Information Service in Turkey. Kaplan YC; Karadaş B; Küçüksolak G; Ediz B; Demir Ö; Sozmen K; Nordeng H Int J Clin Pharm; 2017 Aug; 39(4):783-790. PubMed ID: 28626851 [TBL] [Abstract][Full Text] [Related]
11. Detection of human teratogenic agents. Shepard TH J Pediatr; 1982 Nov; 101(5):810-5. PubMed ID: 7131168 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced teratogenesis. FRASER FC Can Med Assoc J; 1962 Sep; 87(13):683-4. PubMed ID: 13894748 [TBL] [Abstract][Full Text] [Related]
13. Non-Mendelian development defects: animal models and implications for research into human disease. Bull World Health Organ; 1977; 55(4):475-87. PubMed ID: 413638 [TBL] [Abstract][Full Text] [Related]
14. Principles and practice of teratology for the obstetrician. Fisher B; Rose NC; Carey JC Clin Obstet Gynecol; 2008 Mar; 51(1):106-18. PubMed ID: 18303504 [TBL] [Abstract][Full Text] [Related]
15. Risk of drug-induced congenital defects. De Santis M; Straface G; Carducci B; Cavaliere AF; De Santis L; Lucchese A; Merola AM; Caruso A Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):10-9. PubMed ID: 15474237 [TBL] [Abstract][Full Text] [Related]
17. Marked increase in the teratogenicity of the combined administration of the industrial solvent 2-methoxyethanol and radiofrequency radiation in rats. Nelson BK; Conover DL; Brightwell WS; Shaw PB; Werren D; Edwards RM; Lary JM Teratology; 1991 Jun; 43(6):621-34. PubMed ID: 1882353 [TBL] [Abstract][Full Text] [Related]
18. Update on new developments in the study of human teratogens. Shepard TH; Brent RL; Friedman JM; Jones KL; Miller RK; Moore CA; Polifka JE Teratology; 2002 Apr; 65(4):153-61. PubMed ID: 11948561 [TBL] [Abstract][Full Text] [Related]
19. Systematic procedure for the classification of proven and potential teratogens for use in research. Eltonsy S; Martin B; Ferreira E; Blais L Birth Defects Res A Clin Mol Teratol; 2016 Apr; 106(4):285-97. PubMed ID: 26969841 [TBL] [Abstract][Full Text] [Related]
20. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists. Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]